Drug-Resistant TB Treatment: Governments to Save US$740 M Annually
Drug-Resistant TB Treatment: Governments to Save US$740 M Annually By Sharon Atieno With drug-resistant Tuberculosis (DR-TB) affecting about 440,000 people yearly, a new treatment regimen could save governments up to US$740 million annually. This is according to a new study published in PLOS Global Public Health which found that the cost of implementing this new treatment regimen […]




